Clinical Trial Update: Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating romosozumab effects on bone density, muscle mass, and spine surgery outcomes in osteoporosis, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Romosozumab (romosozumab)

Snippet

Sponsor: Nitin Agarwal | Conditions: Osteoporosis, Post-menopausal | Phase 2 | Status: NOT_YET_RECRUITING